scispace - formally typeset
W

William R. Welch

Researcher at Brigham and Women's Hospital

Publications -  159
Citations -  16485

William R. Welch is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Ovarian cancer & Serous fluid. The author has an hindex of 58, co-authored 159 publications receiving 15798 citations. Previous affiliations of William R. Welch include Memorial Hospital of South Bend & Duke University.

Papers
More filters
Journal ArticleDOI

Whole-Genome Allelotyping Identified Distinct Loss-of-Heterozygosity Patterns in Mucinous Ovarian and Appendiceal Carcinomas

TL;DR: Despite histologic similarities between mucinous ovarian carcinomas and metastatic appendiceal carcinomas, they have distinct LOH profiles, which may be used for distinguishing the two diseases.
Journal ArticleDOI

Presence of talc in pelvic lymph nodes of a woman with ovarian cancer and long-term genital exposure to cosmetic talc.

TL;DR: This description of talc in pelvic lymph nodes of a woman with ovarian cancer and decades of exposure to talc may prompt new studies and offer new insights into the biologic basis for the consistent, but debated, association between talc use and ovarian cancer.
Journal ArticleDOI

The Influence of Lactose Consumption on the Association of Oral Contraceptive Use and Ovarian Cancer Risk

TL;DR: The results suggest that, with respect to ovarian cancer, lactose users may be the most likely to benefit from oral contraceptive use and that the benefit may be strongest when oral contraceptives use occurs after age 30 years.
Journal ArticleDOI

Endosalpingiosis as it relates to tubal, ovarian and serous neoplastic tissues: An immunohistochemical study of tubal and Müllerian antigens

TL;DR: This study provides immunophenotypic evidence that ES is more similar to the nFTE than OSE, strengthening the growing body of evidence that all Müllerian serous carcinomas arise from tubal-like epithelium.
Journal ArticleDOI

Genetic imbalance on chromosome 17 in papillary serous carcinoma of the peritoneum.

TL;DR: The evaluation of allelic loss patterns on chromosome 17 to papillary serous carcinoma of the peritoneum (PSCP) is extended, implicating chromosome 17 as a potential location of genetic events important in the pathogenesis of PSCP as well as ovarian cancer.